Zhejiang Huaye Plastics Machinery
301616
Alnera Aluminium
301613
Tibet Duo Rui Pharmaceutical
301075
4
ChengDu Sheng Nuo Biotec
688117
5
Shanghai Zhongzhou Special Alloy Materials
300963
(FY)Dec 31, 2024 | (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | (FY)Dec 31, 2018 | (FY)Dec 31, 2017 | (FY)Dec 31, 2016 | (FY)Dec 31, 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -6.51%131.38M | 188.43%140.53M | -193.11%-158.93M | 70.37%170.69M | -24.22%100.19M | 725.11%132.21M | -124.14%-21.15M | 141.54%87.61M | 59.69%36.27M | -56.28%22.72M |
Non interest income | -6.51%131.38M | 188.43%140.53M | -193.11%-158.93M | 70.37%170.69M | -24.22%100.19M | 725.11%132.21M | -124.14%-21.15M | 141.54%87.61M | 59.69%36.27M | -56.28%22.72M |
-Fees and commissions | -21.96%-5.59M | 2.63%-4.58M | 14.40%-4.7M | -48.33%-5.5M | -7.54%-3.71M | 1.01%-3.45M | -4.07%-3.48M | -22.29%-3.34M | -0.40%-2.73M | -5.00%-2.72M |
-Dividend income | 12.76%4.64M | 8.72%4.11M | -23.68%3.78M | -14.52%4.96M | 65.44%5.8M | -2.39%3.5M | 30.38%3.59M | 27.25%2.75M | -14.94%2.16M | 29.61%2.54M |
Credit losses provision | ||||||||||
Non interest expense | ||||||||||
Selling and administrative expenses | 26.05%359.47K | -4.59%285.17K | -14.26%298.87K | 11.46%348.58K | 8.51%312.74K | 6.05%288.2K | -6.07%271.77K | 12.39%289.32K | -42.30%257.43K | 5.61%446.18K |
-General and administrative expense | 26.05%359.47K | -4.59%285.17K | -14.26%298.87K | 11.46%348.58K | 8.51%312.74K | 6.05%288.2K | -6.07%271.77K | 12.39%289.32K | -42.30%257.43K | 5.61%446.18K |
Income from associates and other participating interests | ||||||||||
Special income (charges) | ||||||||||
Other non-operating income (expenses) | ||||||||||
Income before tax | -6.60%130.95M | 188.01%140.2M | -193.54%-159.29M | 70.59%170.3M | -24.31%99.83M | 715.22%131.9M | -124.55%-21.44M | 142.52%87.31M | 61.82%36M | -56.81%22.25M |
Income tax | ||||||||||
Earnings from equity interest net of tax | ||||||||||
Net income | -6.60%130.95M | 188.01%140.2M | -193.54%-159.29M | 70.59%170.3M | -24.31%99.83M | 715.22%131.9M | -124.55%-21.44M | 142.52%87.31M | 61.82%36M | -56.81%22.25M |
Net Income continuous operations | -6.60%130.95M | 188.01%140.2M | -193.54%-159.29M | 70.59%170.3M | -24.31%99.83M | 715.22%131.9M | -124.55%-21.44M | 142.52%87.31M | 61.82%36M | -56.81%22.25M |
Minority interest income | ||||||||||
Net income attributable to the parent company | -6.60%130.95M | 188.01%140.2M | -193.54%-159.29M | 70.59%170.3M | -24.31%99.83M | 715.22%131.9M | -124.55%-21.44M | 142.52%87.31M | 61.82%36M | -56.81%22.25M |
Preferred stock dividends | ||||||||||
Other preferred stock dividend | ||||||||||
Net income attributable to common stockholders | -6.60%130.95M | 188.01%140.2M | -193.54%-159.29M | 70.59%170.3M | -24.31%99.83M | 715.22%131.9M | -124.55%-21.44M | 142.52%87.31M | 61.82%36M | -56.81%22.25M |
Basic earnings per share | -7.27%7.91 | 186.51%8.53 | -192.15%-9.86 | 70.38%10.7 | -24.52%6.28 | 707.30%8.32 | -124.12%-1.37 | 142.74%5.68 | 61.38%2.34 | -56.85%1.45 |
Diluted earnings per share | -7.27%7.91 | 186.51%8.53 | -192.15%-9.86 | 70.38%10.7 | -24.52%6.28 | 707.30%8.32 | -124.12%-1.37 | 142.74%5.68 | 61.38%2.34 | -56.85%1.45 |
Dividend per share | 0.00%1.85 | 0.00%1.85 | 0.00%1.85 | 0.00%1.85 | 0.00%1.85 | 0.00%1.85 | 0.00%1.85 | 0.00%1.85 | 0.00%1.85 | 0.00%1.85 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Audit Opinions | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | -- | Unqualified Opinion |